AI-driven medical digitalization accelerates, Ping An Health Insurance collaborates + AI empowerment receives bullish outlook from major banks

According to the Zhitong Finance APP, on May 29th, Morgan Stanley's latest research report pointed out that, driven by market β factors such as AI since the beginning of the year, the Chinese healthcare industry has now reached a risk/reward balance point. Major platform companies are adopting different business models and competitive strategies to accelerate revenue under the trend of medical digitization.

In this context, the performance of Ping An Health (01833) is particularly noteworthy. After consolidating with Ping An Group, Ping An Health is providing more value-added services to its financial clients through services such as medical insurance collaboration, while continuously optimizing the application of AI models in different scenarios. Morgan Stanley expects the company's F-end (financial clients) and B-end (enterprise clients) businesses to achieve double-digit growth, supported by the continuous optimization of AI technology for future profit improvement. Morgan Stanley maintains a "Neutral" rating on Ping An Health, with a target price of HKD 7.5.

This judgment aligns with the overall development trend of the Chinese healthcare industry. Supported by AI technology policies and driven by consumption upgrades, the industry has entered a stage of matching profits with valuations. It is worth noting that this trend has also been widely recognized by international financial institutions. JP Morgan recently focused on themes such as AI, robotics, and consumption at its global summit held in Shanghai, with medical digitization being one of the key discussion areas.

Regarding the overall outlook for the Chinese economy, JP Morgan's Chief Economist for China, Zhu Haibin, provided a positive assessment. Zhu Haibin stated that if the current tariff levels are maintained until the end of the year, JP Morgan has raised its forecast for China's GDP growth for the year from 4.1% to 4.8%, with consumption and investment strengthened by policy support. As an important area of consumption upgrade, healthcare benefits from policy dividends and increased market demand.

JP Morgan's Chief Asian and China Equity Strategist, Liu Mingdi, also pointed out that starting from the mid-third quarter of 2023, the Hong Kong market began to outperform other Asian markets. So far this year, the MSCI China Index has performed better than expected, with earnings expectations raised from 14% to 16%. JP Morgan is generally optimistic about the performance of Hong Kong stocks this year, particularly favoring the two high-growth sectors of internet and healthcare.

In this market environment, the development advantages of Ping An Health are further highlighted. As a representative enterprise in the field of internet healthcare, its AI technology applications in intelligent consultations, health management, and other scenarios fully align with industry development trends. Ping An Health's unique advantage lies in its deep collaboration with Ping An Group. Morgan Stanley's report mentioned that the company provides value-added services to financial clients through a medical insurance collaboration model, enhancing user stickiness and increasing business growth potential. At the same time, the company continuously optimizes the application of AI models in medical scenarios to improve operational efficiency and service quality